5E Advanced Materials (NASDAQ:FEAM) Posts Earnings Results

5E Advanced Materials (NASDAQ:FEAM) issued its quarterly earnings data on Tuesday. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.36) by $0.01, FiscalAI reports.

Here are the key takeaways from 5E Advanced Materials’ conference call:

• 5E signed its first offtake heads of agreement for 7,500 tons of boric acid per year, with optional volume up to 10,000 tons, marking a major step toward commercialization and project financing.
• The company said customer interest is growing after a March roadshow, and management expects the new agreement to be the first of additional offtakes that could help support debt underwriting.
• 5E reported successful development of metaboric acid, a higher-value product with about 80% B2O3 equivalent content, and said samples are being tested by customers while a provisional patent was filed.
• The company also launched a ferroboron trial program aimed at serving specialty steel and permanent magnet supply chains, with initial testing underway and customer samples expected in the coming weeks.
• 5E said its balance sheet was strengthened by a $36 million equity offering, and it is progressing with EXIM-related diligence and other financing work to support the next phase of the Fort Katy project.

5E Advanced Materials Trading Down 7.4%

Shares of 5E Advanced Materials stock traded down $0.12 during trading on Tuesday, reaching $1.51. The company’s stock had a trading volume of 323,199 shares, compared to its average volume of 303,617. 5E Advanced Materials has a one year low of $1.17 and a one year high of $7.50. The stock has a market capitalization of $35.50 million, a P/E ratio of -0.57 and a beta of 1.84. The stock has a 50-day moving average price of $1.65 and a two-hundred day moving average price of $2.86.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. HC Wainwright cut their price objective on 5E Advanced Materials from $9.25 to $5.75 and set a “buy” rating for the company in a report on Monday, March 9th. Weiss Ratings reissued a “sell (e+)” rating on shares of 5E Advanced Materials in a report on Monday, April 20th. Finally, Wall Street Zen cut 5E Advanced Materials from a “sell” rating to a “strong sell” rating in a report on Saturday, May 2nd. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $6.38.

Institutional Trading of 5E Advanced Materials

A number of hedge funds and other institutional investors have recently modified their holdings of FEAM. State Street Corp bought a new position in 5E Advanced Materials in the 4th quarter worth approximately $37,000. Goldman Sachs Group Inc. bought a new position in 5E Advanced Materials in the 4th quarter valued at $69,000. Jane Street Group LLC bought a new position in 5E Advanced Materials in the 4th quarter valued at $111,000. XTX Topco Ltd acquired a new stake in shares of 5E Advanced Materials in the 4th quarter valued at $124,000. Finally, &PARTNERS bought a new stake in shares of 5E Advanced Materials during the fourth quarter worth $191,000.

5E Advanced Materials Company Profile

5E Advanced Materials, Inc develops and manufactures high-performance anode materials for lithium-ion batteries, specializing in silicon-carbon composite solutions. The company’s proprietary processes yield anode materials that deliver enhanced energy density, extended cycle life and faster charge rates compared to conventional graphite anodes. These advanced materials are targeted at electric vehicle manufacturers, consumer electronics producers and grid-scale energy storage providers seeking to improve battery performance and sustainability.

The firm operates a pilot production facility in Harrodsburg, Kentucky, where it carries out research, development and small-scale manufacturing to validate its processes and assess commercial viability.